Transdermal estradiol (tE2) is an alternative to luteinizing hormone–releasing hormone (LHRH) agonists as androgen-deprivation therapy in patients with prostate cancer. With tE2, testosterone is ...

People with diabetes may experience changes in their urinary and digestive health, and research shows there may be different effects on the body impacting the development of prostate cancer. Diabetes ...

If you're experiencing symptoms that may indicate prostate cancer, here's what else could be causing them getty Several medical conditions can mimic prostate cancer, causing many of the same symptoms, ...